Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.

Details

Ressource 1Download: 30465016_BIB_936AFB128A84.pdf (178.98 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_936AFB128A84
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
UNIL/CHUV
Title
Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.
Journal
Neurology
Author(s)
Hottinger A.F., de Micheli R., Guido V., Karampera A., Hagmann P., Du Pasquier R.
ISSN
2332-7812 (Print)
ISSN-L
2332-7812
Publication state
Published
Issued date
03/2018
Peer-reviewed
Oui
Volume
5
Number
2
Pages
e439
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
URN
urn:nbn:ch:serval-BIB_936AFB128A846
OAI-PMH
oai:serval.unil.ch:BIB_936AFB128A84
DOI
10.1212/NXI.0000000000000439
Pubmed
30465016
Web of science
000430190400012
Open Access
Yes
Create date
30/11/2018 9:35
Last modification date
20/08/2019 14:56
Usage data